Mdxhealth Sa Adr Stock Analysis
MDXH Stock | USD 1.88 0.17 9.94% |
MDxHealth SA ADR is fairly valued with Real Value of 1.66 and Target Price of 9.5. The main objective of MDxHealth stock analysis is to determine its intrinsic value, which is an estimate of what MDxHealth SA ADR is worth, separate from its market price. There are two main types of MDxHealth's stock analysis: fundamental analysis and technical analysis.
The MDxHealth stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and MDxHealth's ongoing operational relationships across important fundamental and technical indicators.
MDxHealth |
MDxHealth Stock Analysis Notes
About 12.0% of the company outstanding shares are owned by corporate insiders. The book value of MDxHealth was now reported as 0.61. The company recorded a loss per share of 1.53. MDxHealth SA ADR had not issued any dividends in recent years. The entity had 1:10 split on the 14th of November 2023. MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium. Mdxhealth operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 191 people. To find out more about MDxHealth SA ADR contact Michael McGarrity at 32 4 257 70 21 or learn more at https://mdxhealth.com.MDxHealth Quarterly Total Revenue |
|
MDxHealth SA ADR Investment Alerts
MDxHealth SA ADR generated a negative expected return over the last 90 days | |
MDxHealth SA ADR may become a speculative penny stock | |
MDxHealth SA ADR has high historical volatility and very poor performance | |
The company reported the previous year's revenue of 70.19 M. Net Loss for the year was (43.1 M) with profit before overhead, payroll, taxes, and interest of 19.22 M. | |
MDxHealth SA ADR currently holds about 40.02 M in cash with (21.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.57, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Roughly 12.0% of the company outstanding shares are owned by corporate insiders | |
Latest headline from gurufocus.com: AWM Investment Companys Strategic Acquisition of MDxHealth SA Shares |
MDxHealth SA ADR Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to MDxHealth previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
13th of March 2024 Upcoming Quarterly Report | View | |
20th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
13th of March 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
MDxHealth Largest EPS Surprises
Earnings surprises can significantly impact MDxHealth's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2023-08-23 | 2023-06-30 | -0.22 | -0.3 | -0.08 | 36 | ||
2023-05-15 | 2023-03-31 | -0.4132 | -0.5 | -0.0868 | 21 | ||
2022-08-26 | 2022-06-30 | -0.6 | -0.7 | -0.1 | 16 |
MDxHealth Stock Institutional Investors
Shares | Rhumbline Advisers | 2024-06-30 | 72.0 |
MDxHealth Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 84.64 M.MDxHealth Profitablity
The company has Profit Margin (PM) of (0.5) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.26) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.26.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.88) | (0.93) | |
Return On Capital Employed | (0.25) | (0.26) | |
Return On Assets | (0.33) | (0.35) | |
Return On Equity | (5.98) | (5.68) |
Management Efficiency
MDxHealth SA ADR has return on total asset (ROA) of (0.1102) % which means that it has lost $0.1102 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.4082) %, meaning that it created substantial loss on money invested by shareholders. MDxHealth's management efficiency ratios could be used to measure how well MDxHealth manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.93. The current Return On Capital Employed is estimated to decrease to -0.26. As of now, MDxHealth's Intangible Assets are increasing as compared to previous years. The MDxHealth's current Intangibles To Total Assets is estimated to increase to 0.65, while Other Current Assets are projected to decrease to under 1.5 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 0.28 | 0.26 | |
Tangible Book Value Per Share | (2.82) | (2.68) | |
Enterprise Value Over EBITDA | (3.97) | (3.77) | |
Price Book Value Ratio | 14.16 | 14.87 | |
Enterprise Value Multiple | (3.97) | (3.77) | |
Price Fair Value | 14.16 | 14.87 | |
Enterprise Value | 121 M | 127 M |
The management strategies employed by MDxHealth's are designed to enhance shareholder value and ensure long-term growth. We assess the effectiveness of these strategies in our stock analysis.
Operating Margin (0.26) | Profit Margin (0.50) | Beta -394 K | Return On Assets (0.11) | Return On Equity (2.41) |
Technical Drivers
As of the 22nd of November, MDxHealth secures the Mean Deviation of 2.45, risk adjusted performance of (0.17), and Standard Deviation of 3.89. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of MDxHealth SA ADR, as well as the relationship between them.MDxHealth SA ADR Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. MDxHealth middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for MDxHealth SA ADR. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
MDxHealth SA ADR Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific MDxHealth insiders, such as employees or executives, is commonly permitted as long as it does not rely on MDxHealth's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases MDxHealth insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mvm Partners Llc over a year ago Purchase by Mvm Partners Llc of 1000000 shares of MDxHealth |
MDxHealth Outstanding Bonds
MDxHealth issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. MDxHealth SA ADR uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most MDxHealth bonds can be classified according to their maturity, which is the date when MDxHealth SA ADR has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Boeing Co 2196 Corp BondUS097023DG73 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
MGM Resorts International Corp BondUS552953CD18 | View | |
MEAD JOHNSON NUTRITION Corp BondUS582839AH96 | View | |
MEAD JOHNSON NUTRITION Corp BondUS582839AG14 | View | |
AerCap Global Aviation Corp BondUS00773HAA59 | View |
MDxHealth Predictive Daily Indicators
MDxHealth intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of MDxHealth stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 22376.4 | |||
Daily Balance Of Power | 0.85 | |||
Rate Of Daily Change | 1.1 | |||
Day Median Price | 1.79 | |||
Day Typical Price | 1.82 | |||
Price Action Indicator | 0.17 | |||
Period Momentum Indicator | 0.17 |
MDxHealth Forecast Models
MDxHealth's time-series forecasting models are one of many MDxHealth's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary MDxHealth's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About MDxHealth Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how MDxHealth prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MDxHealth shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as MDxHealth. By using and applying MDxHealth Stock analysis, traders can create a robust methodology for identifying MDxHealth entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.61) | (0.64) | |
Operating Profit Margin | (0.39) | (0.41) | |
Net Loss | (0.61) | (0.64) | |
Gross Profit Margin | 0.63 | 0.74 |
Current MDxHealth Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. MDxHealth analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. MDxHealth analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
9.5 | Buy | 1 | Odds |
Most MDxHealth analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand MDxHealth stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of MDxHealth SA ADR, talking to its executives and customers, or listening to MDxHealth conference calls.
MDxHealth Stock Analysis Indicators
MDxHealth SA ADR stock analysis indicators help investors evaluate how MDxHealth stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading MDxHealth shares will generate the highest return on investment. By understating and applying MDxHealth stock analysis, traders can identify MDxHealth position entry and exit signals to maximize returns.
Begin Period Cash Flow | 15.5 M | |
Long Term Debt | 35.6 M | |
Common Stock Shares Outstanding | 25.9 M | |
Total Stockholder Equity | 7.2 M | |
Tax Provision | 128 K | |
Property Plant And Equipment Net | 9.9 M | |
Cash And Short Term Investments | 22.4 M | |
Cash | 22.4 M | |
Accounts Payable | 8.8 M | |
Net Debt | 18.9 M | |
50 Day M A | 2.0968 | |
Total Current Liabilities | 19.5 M | |
Other Operating Expenses | 97.5 M | |
Non Current Assets Total | 91 M | |
Non Currrent Assets Other | 763 K | |
Stock Based Compensation | 665 K |
Complementary Tools for MDxHealth Stock analysis
When running MDxHealth's price analysis, check to measure MDxHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MDxHealth is operating at the current time. Most of MDxHealth's value examination focuses on studying past and present price action to predict the probability of MDxHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MDxHealth's price. Additionally, you may evaluate how the addition of MDxHealth to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Transaction History View history of all your transactions and understand their impact on performance |